Serious Complications of Ozempic, Wegovy, Mounjaro and other GLP-1 Medications GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and others, have been linked to serious gastrointestinal illnesses and serious complications which may result in hospitalization or permanent injury
found a significant reduction in the incidence of coronary artery disease among African American individuals with G6PD-d
This study is part of a trial that started 42 d prior to expected calving and lasted until d 128 postpartum (pp)
Moreover, the pronounced effect of ketogenic therapy on appetite regulation may further supports its effectiveness as a nutritional strategy for obesity management
Patients comfortable with compounded medication from a 503A/503B-credentialed pharmacy
10mg or 15mg) could be sustained through continued treatment, a reduced dose of 5mg, or placebo